30 related articles for article (PubMed ID: 2932588)
1. Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model.
Eck SM; Hoopes PJ; Petrella BL; Coon CI; Brinckerhoff CE
Breast Cancer Res Treat; 2009 Jul; 116(1):79-90. PubMed ID: 18597171
[TBL] [Abstract][Full Text] [Related]
2. Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.
Burfeind P; Chernicky CL; Rininsland F; Ilan J; Ilan J
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7263-8. PubMed ID: 8692980
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by a new bisphosphonate (YM175) of bone resorption induced by the MBT-2 tumour of mice.
Nemoto R; Nishijima Y; Uchida K; Koiso K
Br J Cancer; 1993 May; 67(5):893-7. PubMed ID: 8494721
[TBL] [Abstract][Full Text] [Related]
4. A model of localized osteolysis induced by the MBT-2 tumor in mice and its responsiveness to etidronate disodium.
Nemoto R; Uchida K; Tsutsumi M; Koiso K; Satou S; Satou T
J Cancer Res Clin Oncol; 1987; 113(6):539-43. PubMed ID: 3119600
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease.
Fleisch H
Drugs; 1991 Dec; 42(6):919-44. PubMed ID: 1724640
[TBL] [Abstract][Full Text] [Related]
6. PA-III rat prostate adenocarcinoma cells (review).
Koutsilieris M
In Vivo; 1992; 6(2):199-203. PubMed ID: 1326342
[TBL] [Abstract][Full Text] [Related]
7. Effects of diphosphonate and x-rays on bone lesions induced in rats by prostate cancer cells.
Pollard M; Luckert PH; Scheu J
Cancer; 1988 May; 61(10):2027-32. PubMed ID: 2965968
[TBL] [Abstract][Full Text] [Related]
8. The beneficial effects of diphosphonate and piroxicam on the osteolytic and metastatic spread of rat prostate carcinoma cells.
Pollard M; Luckert PH
Prostate; 1986; 8(1):81-6. PubMed ID: 2935791
[TBL] [Abstract][Full Text] [Related]
9. [Dichloromethylene diphosphonate in the treatment of lytic bone metastases].
Chantraine A; Jung A; van Ouwenaller C; Donath A
Presse Med; 1984 Feb; 13(8):479-82. PubMed ID: 6230629
[TBL] [Abstract][Full Text] [Related]
10. Use of dichloromethylene diphosphonate in metastatic bone disease.
Jung A; Chantraine A; Donath A; van Ouwenaller C; Turnill D; Mermillod B; Kitler ME
N Engl J Med; 1983 Jun; 308(25):1499-501. PubMed ID: 6222257
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat.
Jung A; Bornand J; Mermillod B; Edouard C; Meunier PJ
Cancer Res; 1984 Jul; 44(7):3007-11. PubMed ID: 6233002
[TBL] [Abstract][Full Text] [Related]
12. Effects of dichloromethylene diphosphonate on the osteolytic and osteoplastic effects of rat prostate adenocarcinoma cells.
Pollard M; Luckert PH
J Natl Cancer Inst; 1985 Nov; 75(5):949-54. PubMed ID: 2932588
[TBL] [Abstract][Full Text] [Related]
13. The potential role of bisphosphonates in prostate cancer.
Oades GM; Coxon J; Colston KW
Prostate Cancer Prostatic Dis; 2002; 5(4):264-72. PubMed ID: 12627210
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
